Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock

被引：0
|
作者：
Rinaldo Bellomo
Richard G. Wunderink
Harold Szerlip
Shane W. English
Laurence W. Busse
Adam M. Deane
Ashish K. Khanna
Michael T. McCurdy
Marlies Ostermann
Paul J. Young
Damian R. Handisides
Lakhmir S. Chawla
George F. Tidmarsh
Timothy E. Albertson
机构：
[1] The University of Melbourne,Centre for Integrated Critical Care, Department of Medicine & Radiology
[2] Monash University,Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine
[3] Northwestern University Feinberg School of Medicine,Department of Medicine, Pulmonary and Critical Care Division
[4] Baylor University Medical Center,Department of Medicine, Division of Nephrology
[5] Ottawa Hospital Research Institute,Clinical Epidemiology Program
[6] University of Ottawa,Department of Medicine (Critical Care)
[7] University of Ottawa,School of Epidemiology and Public Health
[8] Emory University,Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine
[9] The University of Melbourne,Department of Medicine and Radiology, Royal Melbourne Hospital
[10] Melbourne Medical School,Department of Anesthesiology, Section on Critical Care Medicine
[11] Wake Forest University School of Medicine,Division of Pulmonary & Critical Care Medicine
[12] Outcomes Research Consortium,Department of Critical Care
[13] University of Maryland School of Medicine,Intensive Care Unit
[14] King’s College London,Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, School of Medicine
[15] Guy’s & St Thomas’ Hospital,Department of Veterans Affairs
[16] Medical Research Institute of New Zealand,undefined
[17] Wellington Hospital,undefined
[18] La Jolla Pharmaceutical Company,undefined
[19] Stanford University School of Medicine,undefined
[20] University of California,undefined
[21] Davis,undefined
[22] Northern California Health System,undefined
来源：
Critical Care | / 24卷
关键词：
Angiotensin I; Angiotensin II; ACE; ACE dysfunction; Sepsis; Vasodilatory shock;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
    Bellomo, Rinaldo
    Wunderink, Richard G.
    Szerlip, Harold
    English, Shane W.
    Busse, Laurence W.
    Deane, Adam M.
    Khanna, Ashish K.
    McCurdy, Michael T.
    Ostermann, Marlies
    Young, Paul J.
    Handisides, Damian R.
    Chawla, Lakhmir S.
    Tidmarsh, George F.
    Albertson, Timothy E.
    CRITICAL CARE, 2020, 24 (01):
  • [2] Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock A Clinical Trial
    Bellomo, Rinaldo
    Forni, Lui G.
    Busse, Laurence W.
    McCurdy, Michael T.
    Ham, Kealy R.
    Boldt, David W.
    Hastbacka, Johanna
    Khanna, Ashish K.
    Albertson, Timothy E.
    Tumlin, James
    Storey, Kristine
    Handisides, Damian
    Tidmarsh, George F.
    Chawla, Lakhmir S.
    Ostermann, Marlies
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (09) : 1253 - 1261
  • [3] Vasopressin effective in reversing catecholamine-resistant vasodilatory shock
    Lim, TW
    Lee, S
    Ng, KS
    ANAESTHESIA AND INTENSIVE CARE, 2000, 28 (03) : 313 - 317
  • [4] The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock
    Albertson, Timothy E.
    Chenoweth, James A.
    Lewis, Justin C.
    Pugashetti, Janelle V.
    Sandrock, Christian E.
    Morrissey, Brian M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 959 - 976
  • [5] Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series
    Tezel, Oguzhan
    Hutson, Tamara K.
    Gist, Katja M.
    Chima, Ranjit S.
    Goldstein, Stuart L.
    Stanski, Natalja L.
    CRITICAL CARE EXPLORATIONS, 2023, 5 (09) : E0978
  • [6] Angiotensin II in Vasodilatory Shock
    Wakefield, Brett J.
    Busse, Laurence W.
    Khanna, Ashish K.
    CRITICAL CARE CLINICS, 2019, 35 (02) : 229 - +
  • [7] Angiotensin II for the Treatment of Vasodilatory Shock
    Gleeson, Patrick J.
    Antonucci, Elio
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2601 - 2601
  • [8] Angiotensin II for the Treatment of Vasodilatory Shock
    Franke, Katharina
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (21) : 1572 - +
  • [9] Angiotensin II for the Treatment of Vasodilatory Shock
    Khanna, Ashish
    English, Shane W.
    Wang, Xueyuan S.
    Ham, Kealy
    Tumlin, James
    Szerlip, Harold
    Busse, Laurence W.
    Altaweel, Laith
    Albertson, Timothy E.
    Mackey, Caleb
    McCurdy, Michael T.
    Boldt, David W.
    Chock, Stefan
    Young, Paul J.
    Krell, Kenneth
    Wunderink, Richard G.
    Ostermann, Marlies
    Murugan, Raghavan
    Gong, Michelle N.
    Panwar, Rakshit
    Hastbacka, Johanna
    Favory, Raphael
    Venkatesh, Balasubramanian
    Thompson, B. Taylor
    Bellomo, Rinaldo
    Jensen, Jeffrey
    Kroll, Stew
    Chawla, Lakhmir S.
    Tidmarsh, George F.
    Deane, Adam M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05): : 419 - 430
  • [10] Hydrocortisone may act through the angiotensin II receptor-2 level in patients with catecholamine-resistant septic shock
    Baykan, Seyma
    Bicakcioglu, Murat
    Bulut, Nilufer
    Yucel, Neslihan
    Ersoy, Yasemin
    Uysal, Nermin Kibrislioglu
    Ozer, Ayse B.
    MINERVA ANESTESIOLOGICA, 2023, 89 (04) : 298 - 305
12345